Elon's Haters Are About to Lose Their Minds...
Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.
Financials
| Curr Year EPS Estimate | -10.30 |
| Next Quarter EPS Estimate | -2.75 |
| Profit Margin | -828.22% |
| Operating Margin | -838.00 |
| Return on Assets | -0.40 |
| Return on Equity | -0.78 |
| Revenue | 9.8M |
| Earnings Per Share | 2,539.72 |
| Revenue Per Share | 2.44 |
| Gross Profit | 2,878,000 |
| Quarterly Revenue Growth | -0.10 |
General
| Name | Tonix Pharmaceuticals Holding Corp |
| Ticker | TNXP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 81 |
About Tonix Pharmaceuticals Holding Corp
Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. Its portfolio focuses on central nervous system disorders, as well as immunology, infectious disease, and rare disease product candidates. The company's products pipeline include TNX-102 SL (cyclobenzaprine HCl sublingual tablet), for the management of fibromyalgia; and is being developed to prevent and treat acute stress reaction, posttraumatic stress disorder, Alzheimer's disease, alcohol use disorder, and multi-site pain associated with Long COVID. It also develops TNX-1300, a double-mutant cocaine esterase, which is in Phase 2 clinical trials for the treatment of cocaine intoxication; and TNX-1900, an intranasal potentiated oxytocin for the treatment of binge eating disorder, adolescent obesity, and bone health in pediatric autism, as well as for social anxiety disorder. In addition, the company develops TNX-1500, an Fc-modified humanized monoclonal antibody indicated to prevent organ transplant rejection, as well as to treat autoimmune conditions; TNX-1700, a recombinant Trefoil Factor Family 2 fusion protein for the treatment of gastric and colorectal cancers; TNX-801 that is in the pre-IND development stage for protection against smallpox and mpox; and TNX-1800, a live virus vaccine for SARS-CoV-2. Its rare disease portfolio consists of TNX-2900, an intranasal potentiated oxytocin to treat for Prader-Willi syndrome. The company has collaboration agreement with Bilthoven Biologicals to advance TNX-801 and Makana Therapeutics, Inc. to study TNX-1500 for human-compatible organs and cells for the treatment of organ failure. Tonix Pharmaceuticals Holding Corp. is headquartered in Chatham, New Jersey.
Earnings
Why Is Rein Therapeutics Stock Trading Higher On Monday?
Rein Therapeutics shares rise after the FDA lifts clinical hold on its Phase 2 RENEW trial for idiopathic pulmonary fibrosis treatment LTI-03.
Elon Musk Teases Two More Tesla Diner Locations After Success In California: Here Are The Future Spots
The EV company opened its first Tesla Diner in July. CEO Elon Musk hints that more locations could be coming.
From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.
Marjorie Taylor Greene Buys 6 Stocks: Buffett, Health Care — And This Magnificent 7 Stock
Marjorie Taylor Greene discloses buying more stocks in October. Here's a look at what she added to her portfolio.
Trump's White House Bathroom Renovation Sparks Fury, Economist Slams 'Clearly Wrong' Inflation Data And More: This Week In Economy
Week economy roundup: From inflation debates and White House renovations to job declines, stock surges, and Fed rate cuts.
Buy This AI Stock Tomorrow Morning? - Ad
A former hedge fund manager known for spotting early winners is sounding the alarm once again. He's turning his focus to a little-known AI company that just earned a near-perfect score in his new proprietary stock grading system. He reveals the name, ticker symbol, and why this could be the smartest AI move of the year.
Elon Musk Calls Out Sam Altman Over Tesla Roadster Refund: 'This Issue Was Fixed and You Received a Refund Within 24 Hours'
Elon Musk and Sam Altman are once again in a public spat, this time over a car.
Warren Buffett's Berkshire Hathaway Bets Big On Consumer Brands Amid Economic Shifts
Warren Buffett and his successor Greg Abel have been directing Berkshire Hathaway towards consumer-centric investments throughout 2025.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Jim Cramer Warns 'Don't Be Fooled' Because Speculators In Gold, Quantum And Nuclear Energy Aren't Going Down 'Without A Fight'
Former hedge fund manager and renowned CNBC TV host Jim Cramer is sounding the alarm on certain speculative pockets of the market, urging investors to sell into the "snapback" momentum if they haven't already done so.
Donald Trump Jr.-Linked Drone Maker Unusual Machines Wins Major Pentagon Deal
Unusual Machines secures its largest Pentagon drone contract to date, with Trump Jr. serving as an adviser but not involved in the deal.
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
Bloom Energy Stock Surges Nearly 17% In Wednesday Pre-Market: What's Going On?
Shares of Bloom Energy Corp soared 18.68% in pre-market trading on Wednesday as third-quarter results surpassed analyst estimates.
Edmunds compares the new BMW X3 and Mercedes-Benz GLC
Compact luxury crossovers are ideal if you’re seeking a compelling blend of utility and style without having to pay full-size luxury SUV pricing. The has been a front-runner since the original model’s introduction in 2003, but it continues to face stiff competition from the .
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
Trump Reportedly Rebuffs Ukraine Missile Appeal After Putin Call: 'Time To Stop...'
President Donald Trump declined to supply Ukraine with Tomahawk missiles after a tense meeting with Ukrainian President Volodymyr Zelensky at the White House on Friday, according to a report.
Trump Warns Supreme Court Tariff Ruling Could 'Literally Destroy' The US: 'We'll Be Struggling For Years'
President Donald Trump warned that the U.S. economy would face significant challenges if the Supreme Court rules against the majority of the tariffs imposed this year.
Central Banks Are Buying More Gold Than Ever-And This U.S. Miner Is Ready to Oblige - Ad
Central banks are rapidly increasing their gold reserves-now nearly 20% of global assets. With rising demand and geopolitical pressure, U.S. gold supply is becoming more strategic than ever.
Kevin O'Leary Said His Mom's Secret 55-Year-Old Investment Portfolio Outperformed Most Hedge Funds—He Decided Then, 'That's How I'm Going To Invest'
Shark Tank's Kevin O'Leary revealed how his mother's disciplined, 55-year investment strategy of diversification and long-term thinking shaped his own approach to building and preserving wealth.
China May Have Made A Breakthrough With Solid State Batteries Offering 600-Mile+ Range, Here's What You Should Know
Chinese researchers' share breakthrough in EV battery technology with solid-state batteries offering 600+ mile range and weighing 220 lbs.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.
2,000 mink released from Iowa farm in what trade group calls 'terrorist act'
One or more intruders broke into an Iowa mink farm and released 2,000 of the furbearing animals in what a trade group called a “terrorist act” under federal law.
Trump's $8.5 Billion Deal With Australia Challenges Chinese Dominance
Trump and Albanese signed a partnership to secure critical mineral supply chains and strengthen defense cooperation.
Elon's New Device Could Launch Biggest IPO of the Decade - Ad
Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.
Consumer Tech News (Oct 27-31): Nvidia Surpasses $5T Market Cap, Trump-Xi Meeting Concludes, Big Tech Report Earnings & More
Apple, Amazon, Microsoft, and Alphabet beat Q3 estimates with revenue and earnings growth. Trump and Xi conclude high-stakes meeting with trade, soybean, and resource agreements, potentially impacting U.S.-China economic relations and global markets.
After winning Trump's $20 billion, President Milei must win votes as Argentine industry reels
BUENOS AIRES, Argentina (AP) — The factory floor used to roar.
Not a Single "Mag 7" on This Legendary Investors List - Ad
A renowned former hedge fund manager - friends to some of the biggest investors in the world - just released a new list of his favorite AI stocks... and not a single Magnificent 7 name made the cut. Instead, an AI stock you've likely never heard of just flagged as "near-perfect" in his new investing scoring system.
MP Materials, USA Rare Earth, Energy Fuels Shares Are Moving Lower: What's Going On?
Share of rare earth stocks are trading lower Monday amid potential U.S.-China negotiations that could delay export controls.
Loggins demands removal of Trump's AI-generated video using ‘Danger Zone’
NEW YORK (AP) — Kenny Loggins is objecting to the use of his music in a social media post showing an artificial intelligence-generated video of dumping excrement from a fighter jet on last weekend's .
Elon's Haters Are About to Lose Their Minds... - Ad
Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.
Why D-Wave Quantum (QBTS) Stock Is Getting Hammered Today
Shares of D-Wave Quantum are trading lower Wednesday afternoon, caught in a broader market downturn.
IonQ, D-Wave Quantum, Rigetti Computing Surge Over 11% Pre-Market: What's Going On?
Shares of IonQ Inc. (NYSE: IONQ), Rigetti Computing (NASDAQ: RGTI), and D-Wave Quantum (NYSE: QBTS) surged in premarket trading on Thursday.
From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.
Stock Market Today: S&P 500, Nasdaq, Dow Jones Futures Rise— Micron, Bitmine, Coinbase In Focus
U.S. stock futures rose on Monday following Friday’s advances. Futures of major benchmark indices were higher.
IonQ, Tempus AI And AeroVironment Are Among Top 10 Large Cap Losers Last Week (Oct. 13-Oct. 17): Are the Others in Your Portfolio?
Top large-cap losers last week included IonQ, Tempus AI, AeroVironment, Astera Labs, Nebius, Kratos, F5, Klarna, Leonardo DRS, and First Horizon, driven by sector pullbacks, policy concerns on defense buybacks, a high-profile cyber breach, and weak earnings.
Buy This AI Stock Tomorrow Morning? - Ad
A former hedge fund manager known for spotting early winners is sounding the alarm once again. He's turning his focus to a little-known AI company that just earned a near-perfect score in his new proprietary stock grading system. He reveals the name, ticker symbol, and why this could be the smartest AI move of the year.
Meta Deepens Clean Energy Pact With ENGIE
Meta signed a new 600MW solar PPA with ENGIE, expanding total clean energy capacity in Texas to over 1.3GW and powering U.S. data centers.
Ford's Recall Count Climbs To 134 In 2025 — CEO Jim Farley Sees It As Biggest 'Near-Term Opportunity'
Ford has been plagued by recalls, tariffs, and quality control issues, with CEO Jim Farley optimistic about addressing them.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Meta Lures Gen Z Talent With Six-Figure Salaries Amid Shrinking Job Opportunities — Here's How Much It's Offering
Meta is reportedly offering hefty paychecks for entry-level software engineering roles, a move seen as a response to the challenging job market for recent graduates.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.